🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Missed Opportunities for HIV Screening in General Practice

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Strasbourg, France
NCT07303114 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult subject (≥18 years) * diagnosed with HIV infection between January 1, 2021, and July 30, 2024 Exclusion Criteria: -Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.
💊

What it tests

  • Not listed
📍

Where

1 site
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy